LJ001

Overview

LJ001 is a broad-spectrum and orally active antiviral agent. LJ001 exerts antiviral activities by binding to viral membranes. LJ001 inhibits TGEV and PDCoV infection . LJ001 decreases TGEV N and PDCoV N-protein expression.

Application

Products | Products > Disease Areas > Infection | Products > Disease Areas > Hepatitis Virus Infection | Products > Disease Areas > Viral Infection | Products > Disease Areas > Hepatitis C Virus Infection | Products > Signaling Pathways > Anti-infection | Products > Research Areas > Infection | Products > Signaling Pathways > HCV | Products > Signaling Pathways > HIV

Product Information

• Catalog No.: HY-16957
• CAS No.: 851305-26-5
• Molecular Formula: C17H13NO2S2
• Molecular Weight: 327.42
• Purity: 98.04%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
• Solubility: ≥ 5 mg/mL (15.27 mM); Clear solution
• Availability: In-stock

Source

Original product source